Cowen and Company’s Acceleron Pharma XLRN Stock Holding History

Cowen and Company’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,253	Closed	-$560K	–	901
2021 Q3	$560K	Buy	+3,253	New	+$425K	0.03%	186

Cowen and Company's XLRN Position: Q4 2021 in Review

Cowen and Company sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,253 shares — an estimated $560K sold.

Cowen and Company first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $560K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Cowen and Company reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Cowen and Company sold 3,253 Acceleron Pharma shares in Q4 2021, an estimated $560K.
Cowen and Company first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Cowen and Company's Acceleron Pharma position peaked at $560K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.